https://www.curesponse.com/curesponse-and-rafael-announce-colaboration/ 2023-01-01T16:01:15+00:00 https://www.curesponse.com/wp-content/uploads/2022/12/logo_globeNewswire.png https://www.curesponse.com/curesponse-interviewed-on-israel-channel-13/ 2023-01-01T16:10:00+00:00 https://www.curesponse.com/wp-content/uploads/2022/01/logo_channel13.png https://www.curesponse.com/curesponse-featured-in-the-marker-in-hebrew/ 2023-01-01T16:12:55+00:00 https://www.curesponse.com/wp-content/uploads/2022/12/logo_themarker.png https://www.curesponse.com/curesponse-raises-usd-6-million-in-hebrew/ 2023-01-01T16:13:25+00:00 https://www.curesponse.com/wp-content/uploads/2022/12/logo_geektime.png https://www.curesponse.com/curesponse-secures-additional-usd-8-million-funding/ 2023-01-01T16:15:07+00:00 https://www.curesponse.com/wp-content/uploads/2022/12/logo_globeNewswire.png https://www.curesponse.com/curesponse-to-exhibit-at-asco-2022/ 2023-01-03T08:27:36+00:00 https://www.curesponse.com/wp-content/uploads/2022/05/News_Asco2022_logo.jpg https://www.curesponse.com/curesponse-to-present-at-biomed-israel-2022/ 2023-01-03T08:28:39+00:00 https://www.curesponse.com/wp-content/uploads/2022/04/News_Biomed2022_logo.jpg https://www.curesponse.com/curesponse-publishes-new-study-in-nature-cancer/ 2023-01-10T07:18:30+00:00 https://www.curesponse.com/wp-content/uploads/2022/12/logo_nature_cancer.png https://www.curesponse.com/curesponse-shows-applicability-with-next-generation-immuno-oncology-drugs/ 2023-01-17T13:06:42+00:00 https://www.curesponse.com/wp-content/uploads/2022/12/logo_CISION.png https://www.curesponse.com/wp-content/uploads/2022/12/logo_CISION.png https://www.curesponse.com/curesponse-presents-positive-interim-results-at-aacr-2021/ 2023-01-17T13:08:09+00:00 https://www.curesponse.com/wp-content/uploads/2021/04/logo-aacr.jpg https://www.curesponse.com/clalit-health-services-to-provide-commercial-coverage-for-the-cresponse-test/ 2023-02-23T16:19:05+00:00 https://www.curesponse.com/wp-content/uploads/2023/02/yahoo-finance.png https://www.curesponse.com/curesponse-discuss-with-the-jerusalem-post-its-cresponse-test-that-can-predict-which-drugs-will-benefit-individual-cancer-patients/ 2023-11-05T12:59:25+00:00 https://www.curesponse.com/wp-content/uploads/2023/11/th.jpg https://www.curesponse.com/curesponse-discusses-with-the-jerusalem-post-its-innovative-cresponse-test-that-helps-tailor-the-optimal-treatment-for-breast-cancer-patients/ 2023-11-05T13:00:00+00:00 https://www.curesponse.com/wp-content/uploads/2023/11/th.jpg https://www.curesponse.com/curesponse-to-collaborate-with-edx-medical-group-plc-on-marketing-the-cresponse-cancer-assay-in-the-uk-sweden-finland-norway-and-denmark/ 2024-11-07T12:11:45+00:00 https://www.curesponse.com/wp-content/uploads/2024/11/download-1.png https://www.curesponse.com/curesponse-discusses-its-cancer-prediction-test-with-ynet/ 2024-11-11T09:24:13+00:00 https://www.curesponse.com/wp-content/uploads/2023/03/New-Project-2.png https://www.curesponse.com/curesponse-selected-for-israeli-innovation-dream-team-2024-2025/ 2024-11-11T09:26:52+00:00 https://www.curesponse.com/wp-content/uploads/2024/04/israels-dream-team.png https://www.curesponse.com/a-new-publication-highlights-the-use-of-cresponse-in-the-assessment-of-response-to-treatments-for-pancreatic-cancer/ 2025-05-06T09:52:04+00:00 https://www.curesponse.com/wp-content/uploads/2023/11/newswire-1.jpg https://www.curesponse.com/curesponse-presents-positive-preliminary-clinical-results/ 2025-05-06T09:52:32+00:00 https://www.curesponse.com/wp-content/uploads/2023/11/newswire-1.jpg https://www.curesponse.com/functional-oncology-platform-london-summit/ 2025-05-06T10:03:55+00:00 https://www.curesponse.com/wp-content/uploads/2025/05/Tumour-Models-Summit.jpg https://www.curesponse.com/curesponse-israel-healthtech-roadshow/ 2025-05-06T10:04:52+00:00 https://www.curesponse.com/wp-content/uploads/2025/02/HealthTech_left_aligned_526x93.jpg https://www.curesponse.com/curesponse-european-patent-colorectal/ 2025-05-06T10:07:05+00:00 https://www.curesponse.com/wp-content/uploads/2025/04/EPO_left_aligned_526x93.jpg